MedNews: Nyxoah raises $27 million for its breakthrough treatment alternatives for Obstructive Sleep Apnea through neuromodulation
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA).
top of page
Strategists and Implementers
for growing companies globally
MedNews from Medical and Pharma Insider
MedNews features medical, pharma, biotech, healthcare, medical device and healthcare IT news focused on financings, business transactions and strategic relationships.
Sep 9
MedNews: CSA Medical raises $53 million to advance its RejuvenAir System utilizing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis
This round will fund the company though expected FDA premarket approval and the building of a commercialization strategy
Aug 23
MedNews: XII MEDICAL closes $45 million financing to advance its neuromodulation therapy for obstructive sleep apnea
It is estimated that 425 million people, globally, have moderate to severe obstructive sleep apnea
Aug 22
MedNews: Retension Pharmaceuticals raises $10.4 million to fund clinical trials for patients suffering from resistant and uncontrolled hypertension
Retension Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing RTN-001 as a therapy for patients with hypertension.
Aug 11
MedNews: EHE Health, the leader in employer-based preventive healthcare is acquired by Consello Capital
EHE's comprehensive, evidence-based preventive care provides 100% of the recommended screenings, resulting in more health conditions being f
Aug 8
TechNews: Cyclotron technology innovator and isotope manufacturer IONETIX closes financing led by Tees River and Eli Lilly and Company
distribution supply chain includes contract drug manufacturing and "white glove" distribution logistics, allowing global access...
Aug 4
MedNews: Clinical biopharmaceutical company Sellas Life Sciences, focused on the development of novel therapies for a broad range of cancer indications, raises $21 million
SELLAS is a clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications
Jul 27
MedNews: AI-enabled biotechnology company ReviR Therapeutics raises $30 million to advance oral genetic medicines for multiple CNS disorders
ReviR Therapeutics is a biopharmaceutical company focused on the development of RNA-targeting small molecule therapies
Jul 25
MedNews: clinical-stage biotherapeutics company Rani Therapeutics, focused on the oral delivery of biologics and drugs, prices $10 million offering
Our mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful injections with a pill
Jul 10
ReShape Lifesciences, a weight loss and metabolic health-solutions company to merge with clinical stage specialty pharmaceutical company Vyome, and acquire assets of metabolic health Biorad Medisys
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and Vyome Therapeutics,
Jul 6
MedNews: Adult stem cell therapeutics developer BrainStorm Cell Therapeutics (Nasdaq: BCLI) raises $4 million
Autologous MSC-NTF cells have received Orphan Drug designation status from the FDA and the European Medicines Agency
Jul 1
MedTalks - An interview with Brian Frenzel, CEO of TOSK discussing the company's business and its investment opportunities
TK-90 has completed “proof of concept” in Phase 2a clinical studies demonstrating safety and efficacy in head and neck cancer patients...
Jun 30
MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease
The company’s discovery engine builds on Dr. Choe’s research uncovering a unique pheromone language shared by roundworms
Jun 18
MedNews: Ehealth Technologies partners with CancerX and the White House cancer moonshot to boost cancer innovation
Our patented technology with embedded AI collects and clinically organizes patient data, including records, lab results, images...
Jun 16
MedNews: Avinger (Nasdaq: AVGR) prices share and warrant offering of up to $24 million at $1.66 per share
Avinger is a medical device company that has developed the first image-guided, catheter-based system for patients with vascular disease.
Jun 14
MedNews: InduPro raises $85 Million to advance next-generation, proximity-based protein therapeutics for the treatment of cancer and autoimmune diseases
The financing will support the advancement of the first expected clinical product candidate targeting cancer tissue
Jun 10
MedNews: Employee well being technology provider Navigate Wellbeing partners with content solution provider Caravan Wellness to benefit employees
This collaboration focuses on innovative workplace wellness programs, financial well-being education, mental and emotional health...
Jun 8
MedNews: Immuno-pharma research and development company, AIM ImmunoTech raises $2 million from one investor
The Company’s lead product is a first-in-class investigational drug for cancers, viral diseases and disorders of the immune system
Jun 6
MedNews: BMI OrganBank announces promising preclinical kidney transplant data for a novel medical device to reduce the wait-list for organ transplants
BMI OrganBank develops novel perfusion systems that can preserve and recondition organs and tissues.
Jun 1
MedNews: GRIT Biotechnology and Quangang Pharmaceutical partner to jointly develop a globally standardized IL-2 for solid tumor patients receiving T-cell therapy
Grit is a clinical stage cell therapy company leading the tumor infiltrating lymphocytes (TILs) therapy development
May 29
MedNews: MediLink Therapeutics enters into a multi-target technology platform license with the immunotherapy company BioNTech (Nasdaq: BNTX) for therapies for cancer and other serious diseases
MediLink Therapeutics, founded in 2020, is a clinical stage biotech company dedicated to developing conjugated drugs
May 28
MedNews: Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for breakthroughs in diagnostics innovation, engineering and manufacturing
Both Roche and Hitachi High-Tech share the vision to drive innovation in in-vitro diagnostics to solve healthcare challenges
May 26
MedNews: Lilly increases its manufacturing investment in its newest Indiana site to $9 Billion to boost API production for Tirzepatide for weight loss and diabetes and its pipeline medicines
This investment represents the single largest investment in synthetic medicine API manufacturing in US history.
May 25
MedNews: South Korea based HoneyNaps secures $11.6 million to advance its FDA approved AI sleep diagnosis software
SOMNUM is an algorithm that is integrable into any medical and healthcare market using real-time large-scale bio signal.
May 23
MedNews: Clinical-stage pharmaceutical company Inhibikase Therapeutics (Nasdaq: IKT) raises $4 million
The company's multi-therapeutic pipeline is pursuing Parkinson's-related disorders of the brain and GI tract
May 22
MedNews: Progentos Therapeutics raises $65 million for treatments for multiple sclerosis and other degenerative diseases
Progentos is developing first-in-class compounds to induce endogenous oligodendrocyte progenitor cells to remyelinate axons in patients
May 21
MedNews: The cancer and life-threatening infectious diseases medical therapeutic company Aethlon Medical (Nasdaq: AEMD) raises $4.7 million
In human studies the Hemopurifier has demonstrated the removal of life-threatening viruses and the removal of harmful exosomes
May 11
MedNews: Backpack Healthcare closes $14 million funding to revolutionize pediatric mental health care
the company offers an app and teletherapy services designed to provide accessible, inclusive, and comprehensive mental health support
May 10
MedNews: Medical device company R3 Vascular announces $87 million financing
R3 Vascular will use the proceeds to support the ELITE FDA IDE trial of its bioresorbable scaffold, MAGNITUDE, for below-the-knee pad
May 9
MedNews: Averto Medical debuts with $30 million financing to advance medical device that avoids the need for ostomy
oloSeal™ has the potential to help over 100,000 patients annually who undergo colorectal surgeries
May 6
MedNews: Context Therapeutics (Nasdaq CNTX) raises $100 million in a private placement
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors.
May 1
Vitestro raises €20 million for its autonomous blood draw device
With its autonomous blood draw technology Vitestro is transforming the blood draw industry globally.
Apr 30
MedNews: FDA Grants Full Approval for Pfizer's and Genmab's TIVDAK to Treat Recurrent or Metastatic Cervical Cancer
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent...
Apr 27
MedNews: Treatment provider for severe mental illness, Amae Health, raises $15 million
By focusing on the individual as a whole person and addressing their long-term needs, we create lasting change for our members.
bottom of page